Pliant Therapeutics (PLRX) Return on Sales [ROS] (2020 - 2024)
Pliant Therapeutics (PLRX) recorded Return on Sales [ROS] of -78404.03% in Q1 2024, down 75243.75 percentage points from -3160.29% a year earlier and down 66749.29 percentage points from the prior quarter.
Powered by 
Analysis
Pliant Therapeutics (PLRX) Return on Sales [ROS] (2020 - 2024) Analysis & Trends
For FY2023, Pliant Therapeutics reported Return on Sales [ROS] of -11654.75%, down 10341.38 percentage points from FY2022.
- Annual Return on Sales [ROS] has declined for four straight years, with a four-year change of -11652.59 percentage points (FY2019 to FY2023).
- Across earlier years, Return on Sales [ROS] came in at -1313.37% in FY2022 (-25.27 pp), -1288.10% in FY2021 (-1188.51 pp), -99.59% in FY2020 (-97.43 pp) and -2.16% in FY2019.
- The Q1 2024 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q1 2020.
- On a year-over-year basis, Return on Sales [ROS] has declined for seven consecutive quarters, with an average year-over-year change of -13451.47 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 686.12 percentage points in Q2 2022, against a drop of 75243.75 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -11654.75% (Q4 2023), -4922.65% (Q3 2023) and -19083.87% (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | Pliant Therapeutics | 65.02 Mn | 65.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -78,404.03% |
| Dec 31, 2023 | -11,654.75% |
| Sep 30, 2023 | -4,922.65% |
| Jun 30, 2023 | -19,083.87% |
| Mar 31, 2023 | -3,160.29% |
| Dec 31, 2022 | -1,903.31% |
| Sep 30, 2022 | -2,155.67% |
| Jun 30, 2022 | -594.15% |
| Mar 31, 2022 | -2,258.69% |
| Dec 31, 2021 | -1,230.57% |
| Sep 30, 2021 | -1,684.04% |
| Jun 30, 2021 | -1,280.27% |
| Mar 31, 2021 | -1,054.23% |
| Dec 31, 2020 | -430.52% |
| Sep 30, 2020 | -346.09% |
| Jun 30, 2020 | -471.56% |
| Mar 31, 2020 | 38.04% |
API Access
Pliant Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "PLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();